Back to Search Start Over

The 5-Phosphatase SHIP2 Promotes Neutrophil Chemotaxis and Recruitment.

Authors :
Michael, Melina
McCormick, Barry
Anderson, Karen E.
Karmakar, Utsa
Vermeren, Matthieu
Schurmans, Stéphane
Amour, Augustin
Vermeren, Sonja
Source :
Frontiers in Immunology; 4/19/2021, Vol. 11, pN.PAG-N.PAG, 13p
Publication Year :
2021

Abstract

Neutrophils, the most abundant circulating leukocytes in humans have key roles in host defense and in the inflammatory response. Agonist-activated phosphoinositide 3-kinases (PI3Ks) are important regulators of many facets of neutrophil biology. PIP3 is subject to dephosphorylation by several 5' phosphatases, including SHIP family phosphatases, which convert the PI3K product and lipid second messenger phosphatidylinositol 3,4,5-trisphosphate (PIP3) into PI(3,4)P2, a lipid second messenger in its own right. In addition to the leukocyte restricted SHIP1, neutrophils express the ubiquitous SHIP2. This study analyzed mice and isolated neutrophils carrying a catalytically inactive SHIP2, identifying an important regulatory function in neutrophil chemotaxis and directionality in vitro and in neutrophil recruitment to sites of sterile inflammation in vivo , in the absence of major defects of any other neutrophil functions analyzed, including, phagocytosis and the formation of reactive oxygen species. Mechanistically, this is explained by a subtle effect on global 3-phosphorylated phosphoinositide species. This work identifies a non-redundant role for the hitherto overlooked SHIP2 in the regulation of neutrophils, and specifically, neutrophil chemotaxis/trafficking. It completes an emerging wider understanding of the complexity of PI3K signaling in the neutrophil, and the roles played by individual kinases and phosphatases within. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
16643224
Volume :
11
Database :
Complementary Index
Journal :
Frontiers in Immunology
Publication Type :
Academic Journal
Accession number :
150300817
Full Text :
https://doi.org/10.3389/fimmu.2021.671756